Rhabdomyolysis after recombinant zoster vaccination: a rare adverse reaction

We present a case report describing a potential rare adverse reaction of the recombinant zoster vaccination. This patient is a 60-year-old female who was admitted for severe rhabdomyolysis after receiving the vaccine. The patient's symptoms and CPK improved with aggressive hydration over severa...

Full description

Saved in:
Bibliographic Details
Published inJournal of community hospital internal medicine perspectives Vol. 11; no. 1; pp. 145 - 146
Main Authors Rajaratnam, Nishan, Govil, Swati, Patel, Rutwik, Ahmed, Mohamed, Elias, Sameh
Format Journal Article
LanguageEnglish
Published United States Greater Baltimore Medical Center 26.01.2021
Taylor & Francis
Subjects
adverse effect
Case Report
Case reports
Immunization
Physicians
Rhabdomyolysis
Risk analysis
Risk factors
shingles
Side effects
Vaccination
vaccine
Vaccines
zoster
vaccine
zoster
Rhabdomyolysis
adverse effect
shingles
vaccination
Online AccessGet full text

Cover

More Information
Summary:We present a case report describing a potential rare adverse reaction of the recombinant zoster vaccination. This patient is a 60-year-old female who was admitted for severe rhabdomyolysis after receiving the vaccine. The patient's symptoms and CPK improved with aggressive hydration over several days. The patient did not have any known or reported common risk factors for rhabdomyolysis and the Naranjo Score was used to determine the likelihood of an adverse drug reaction. This is a relevant case to discuss in order to make physicians aware of a possible rare and lethal adverse effect due to a common vaccination.
ISSN:2000-9666
2000-9666
DOI:10.1080/20009666.2020.1841878